OP0167 Efficacy and safety of CNTX-4975 in subjects with moderate to severe osteoarthritis knee pain: 24-week, randomized, double-blind, placebo-controlled, dose-ranging study
Stevens, R, Petersen, D, Ervin, J, Nezzer, J, Nieves, Y, Campbell, J, Guedes, K, Burges, R, Hanson, P
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study
Altman, Roy D, Strand, Vibeke, Hochberg, Marc C, Gibofsky, Allan, Markenson, Joseph A, Hopkins, William E, Cryer, Byron, Kivitz, Alan, Nezzer, Jennifer, Imasogie, Olaolu, Young, Clarence L
Published in Postgraduate medicine (03.09.2015)
Published in Postgraduate medicine (03.09.2015)
Get more information
Journal Article